- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Blue chip stocks
U.S. Pharmaceuticals & Biotech Blue chip stocks
Results
13
13 companies
Illumina
Market Cap: US$12.4b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$74.53
7D
-3.3%
1Y
-33.9%
Alnylam Pharmaceuticals
Market Cap: US$35.7b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$269.81
7D
4.9%
1Y
74.8%
Exact Sciences
Market Cap: US$10.1b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$53.99
7D
20.5%
1Y
-12.1%
Vertex Pharmaceuticals
Market Cap: US$128.6b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VRTX
US$450.03
7D
-10.6%
1Y
9.7%
Natera
Market Cap: US$21.4b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$155.50
7D
0.4%
1Y
60.1%
Revvity
Market Cap: US$11.2b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$90.42
7D
-4.5%
1Y
-12.4%
Viatris
Market Cap: US$10.3b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$8.48
7D
1.7%
1Y
-27.6%
Neurocrine Biosciences
Market Cap: US$10.9b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$118.92
7D
10.9%
1Y
-16.9%
BeiGene
Market Cap: US$27.4b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$241.75
7D
-3.2%
1Y
50.6%
AbbVie
Market Cap: US$346.8b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$187.15
7D
-3.3%
1Y
15.1%
Eli Lilly
Market Cap: US$737.5b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$775.12
7D
-12.4%
1Y
-0.3%
Incyte
Market Cap: US$12.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$59.61
7D
-1.4%
1Y
9.6%
Exelixis
Market Cap: US$11.0b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$36.86
7D
-4.4%
1Y
66.4%